Silco Pharmaceuticals Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Cash & Equivalents	31.9	28.7	30.76	26.72	53.03	101.97
Short-Term Investments	-	1.77	18.97	37.91	19.41	155.95
Cash & Short-Term Investments	31.9	30.47	49.73	64.63	72.44	257.92
Cash Growth	-48.73%	-38.73%	-23.04%	-10.79%	-71.91%	-14.52%
Receivables	429.81	419.59	377.51	389.24	390.53	484.99
Inventory	448.06	444.1	444.14	457.84	449.45	454.71
Prepaid Expenses	-	0.59	-	0.21	0.21	0.21
Other Current Assets	128.28	160.19	133.55	136.83	139.59	126.93
Total Current Assets	1,038	1,055	1,005	1,049	1,052	1,325
Property, Plant & Equipment	1,742	1,767	1,762	1,671	1,643	1,334
Other Long-Term Assets	0	-	-0	-0	0	0
Total Assets	2,781	2,822	2,767	2,720	2,696	2,659
Accounts Payable	9.03	9.6	9.75	12.33	16.15	16.58
Accrued Expenses	10.91	9.18	9.27	16.93	21.21	14.87
Current Portion of Leases	3.78	4.26	-	4.11	3.77	-
Current Income Taxes Payable	193.51	285.19	273.7	255.21	240.41	223.62
Other Current Liabilities	2.16	2.56	3.04	2.33	1.42	4.79
Total Current Liabilities	219.39	310.8	295.76	290.91	282.96	259.86
Long-Term Leases	-	5.31	-	-	4.11	-
Long-Term Deferred Tax Liabilities	154.9	153.71	151.73	150.21	140.5	152.3
Other Long-Term Liabilities	0	0	-0	-	0	-0
Total Liabilities	374.29	469.82	447.5	441.11	427.57	412.17
Common Stock	1,038	1,038	1,038	1,038	1,038	1,038
Retained Earnings	1,368	1,316	1,289	1,251	1,230	1,208
Comprehensive Income & Other	-	-1.15	-6.92	-10.69	-0.37	-
Shareholders' Equity	2,406	2,352	2,320	2,279	2,268	2,246
Total Liabilities & Equity	2,781	2,822	2,767	2,720	2,696	2,659
Total Debt	3.78	9.57	-	4.11	7.89	-
Net Cash (Debt)	28.12	20.9	49.73	60.51	64.56	257.92
Net Cash Growth	-45.47%	-57.97%	-17.82%	-6.26%	-74.97%	-14.52%
Net Cash Per Share	0.28	0.20	0.48	0.58	0.62	2.48
Filing Date Shares Outstanding	102.08	103.81	103.81	103.81	103.81	103.81
Total Common Shares Outstanding	102.08	103.81	103.81	103.81	103.81	103.81
Working Capital	818.66	744.14	709.17	757.83	769.27	1,065
Book Value Per Share	23.57	22.66	22.35	21.95	21.85	21.64
Tangible Book Value	2,406	2,352	2,320	2,279	2,268	2,246
Tangible Book Value Per Share	23.57	22.66	22.35	21.95	21.85	21.64
Land	-	74.85	74.85	74.85	74.85	74.85
Buildings	-	1,083	1,004	880.25	700.05	477.1
Machinery	-	1,576	1,524	1,443	1,320	1,317
Construction In Progress	-	128.1	174.96	197.38	394.59	243.52

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.